As a leader in our industry since 2000, we continually invest in research to demonstrate the benefits of our products for your health. So far, three independent clinical studies have scientifically demonstrated that AminoLock Collagen regenerates collagen in cartilage and reduces joint pain related to osteoarthritis. In addition, we work closely with McGill University to expand our knowledge of the benefits of our proprietary ingredient.
Genacol works closely with Dr. Pierre Haddad as a scientific advisor to better understand the positive features generated by hydrolysed collagen, alone or with other natural components in the human body.
Dr. Haddad is a professor in the Department of Pharmacology at a major Canadian University where he obtained his PhD in 1986. In the following years, he pursued his postdoctoral studies (one at the University of Vienna in Austria and one at at Yale University in the United States).
Passionate and always searching for answers in the world of natural health, he is the author of more than 140 publications in scientific journals of which more than two-thirds are on natural health products.
The first study was conducted over a six-month period at the University of Liège and included 200 subjects, aged 50 and over, who suffered from joint pain. The objective of the study was to demonstrate the efficacy of AminoLock® Collagen (1200 mg) in relieving joint pain, as compared to a placebo.
Results: Patients who were given AminoLock® Collagen instead of a placebo obtained better scores on the VAS, a scale used to measure pain levels. The results demonstrated AminoLock® Collagen’s superior efficacy in relieving joint pain.
The second study was conducted at Veterans Memorial Medical Centre in the Philippines.
The objective of the study was to demonstrate the efficacy of AminoLock® Collagen in relieving knee osteoarthritis pain, as compared to a nonsteroidal anti-inflammatory drug. The study was conducted over a six-month period and included 113 patients.
Result: After 6 months of treatment, patients who were given AminoLock® Collagen reported a statistically significant reduction in pain, whereas the group given the anti-inflammatory drug reported no significant difference with respect to their pain levels.
The third clinical study was conducted at the University of Santo Tomas Hospital in the Philippines.
The objective of the study was to determine the efficacy of AminoLock® Collagen, combined with physical exercise, in treating osteoarthritis of the knee.
The placebo-controlled, triple-blind study included 109 subjects, aged 50 and older, who had experienced knee pain for over a month.
Results: The study demonstrated that AminoLock® Collagen, combined with exercise, relieves pain, improves general joint function, and produces interarticular and periarticular structural changes.
Recently, ConsumerLab.com, an independent organization that evaluates nutritional products in the USA, recognized Genacol’s clinical study as: ONE OF THE LARGEST STUDIES ABOUT COLLAGEN HYDROLYSATE.
The report also mentions that after 6 months of taking the collagen (Genacol) 51.6% of the participants reported a reduction in pain (Bruyere, Comp Ther Med 2012)